Dermatan Sulfate
Concept
Vocabulary Service
Overview
subject area of
-
A Low Molecular Weight Heparin Alters the Fetal Coagulation System in the Pregnant Sheep Academic Article
-
A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke Academic Article
-
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia Academic Article
-
An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus. Academic Article
-
Anticoagulant Mechanisms of Orgaran (Org 10172) and Its Fraction with High Affinity to Antithrombin III (Org 10849) Academic Article
-
Comparison of Heparin- and Dermatan Sulfate-mediated Catalysis of Thrombin Inactivation by Heparin Cofactor II Academic Article
-
Covalent Heparin Cofactor II-Heparin and Heparin Cofactor II-Dermatan Sulfate Complexes Academic Article
-
Current agents for the treatment of patients with heparin-induced thrombocytopenia Academic Article
-
DOUBLE-BLIND RANDOMISED TRIAL OF ORG 10172 LOW-MOLECULAR-WEIGHT HEPARINOID IN PREVENTION OF DEEP-VEIN THROMBOSIS IN THROMBOTIC STROKE Academic Article
-
Dermatan sulphate in heparin-induced thrombocytopenia Academic Article
-
Effect of Covalent Serpin–Heparinoid Complexes on Plasma Thrombin Generation on Fetal Distal Lung Epithelium Academic Article
-
Effect of Dermatan Sulphate on Activated Partial Thromboplastin Time Determined with Different Reagents Academic Article
-
Effect of Nonspecific Binding to Plasma Proteins on the Antithrombin Activities of Unfractionated Heparin, Low-Molecular-Weight Heparin, and Dermatan Sulfate Academic Article
-
Effects of Dermatan Sulfate and Heparin on Inhibition of Thrombus Growth in Vivo Academic Article
-
Effects of Sulfated Polysaccharides on Inhibition of Thrombus Formation initiated by Different Stimuli Academic Article
-
Effects of Unfractionated Heparin, Dermatan Sulfate and Low Molecular Weight Heparin on Vessel Wall Permeability in Rabbits Academic Article
-
Evidence for thrombin binding to dermatan sulphate sites in the rabbit aorta subendothelium in vitro Academic Article
-
Extraction and analysis of glycosaminoglycans from intima-media of single rabbit aortae: effect of balloon catheter de-endothelialization on the content and profile of glycosaminoglycans Academic Article
-
Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma. Academic Article
-
Glycosaminoglycans Bind Factor Xa in a Ca2+-Dependent Fashion and Modulate Its Catalytic Activity Academic Article
-
Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect Academic Article
-
Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways. Academic Article
-
Heparin Cofactor II and Other Endogenous Factors in the Mediation of the Antithrombotic and Anticoagulant Effects of Heparin and Dermatan Sulfate Academic Article
-
Heparin-Induced Thrombocytopenia: A Ten-Year Retrospective Academic Article
-
Heparin-induced thrombocytopenia and its treatment. Conference Paper
-
Heparin-induced thrombocytopenia in intensive care patients Academic Article
-
Heparin-induced thrombocytopenia in the critical care setting: Diagnosis and management^ Academic Article
-
Heparin/Heparan Sulfate (HP/HS) Interacting Protein (HIP) Supports Cell Attachment and Selective, High Affinity Binding of HP/HS Academic Article
-
Heparin‐induced thrombocytopenia – therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4–heparin complexes Academic Article
-
In vivo activity of a new heparinoid. Academic Article
-
Increased deposition of chondroitin/dermatan sulfate glycosaminoglycan and upregulation of β1,3-glucuronosyltransferase I in pulmonary fibrosis Academic Article
-
Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate Academic Article
-
Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma Academic Article
-
Is Heparin the Ideal Anticoagulant for Cardiopulmonary Bypass? Dermatan Sulphate May Be an Alternate Choice Academic Article
-
Lack of Relationship Between Enhanced Bleeding Induced by Heparin and Other Sulfated Polysaccharides and Enhanced Catalysis of Thrombin Inhibition Academic Article
-
Limitations of conventional treatment options for heparin-induced thrombocytopenia. Academic Article
-
Low molecular weight heparins and heparinoids Academic Article
-
Low-Molecular-Weight Heparinoid Orgaran Is More Effective Than Aspirin in the Prevention of Venous Thromboembolism After Surgery for Hip Fracture Academic Article
-
Mechanisms for Inhibition of the Generation of Thrombin Activity by Sulfated Polysaccharides Academic Article
-
Mechanisms for the anticoagulant effect of heparin and related polysaccharides. Academic Article
-
Modulation of the Enzymatic Activity of α-Thrombin by Polyanions: Consequences on Intrinsic Activation of Factor V and Factor VIII Academic Article
-
Molecular Basis for the Susceptibility of Fibrin-bound Thrombin to Inactivation by Heparin Cofactor II in the Presence of Dermatan Sulfate but Not Heparin Academic Article
-
Molecular Mapping of the Thrombin-Heparin Cofactor II Complex Academic Article
-
Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia Academic Article
-
Orgaran in the Prevention of Deep Vein Thrombosis in Stroke Patients Academic Article
-
Parenteral Anticoagulants Academic Article
-
Parenteral Anticoagulants Academic Article
-
Pharmacological Actions of Sulodexide Academic Article
-
Plasma Anticoagulant Mechanisms of Heparin, Heparan Sulfate, and Dermatan Sulfate Academic Article
-
Prevention and treatment of thrombosis: novel strategies arising from our understanding the healthy endothelium. Academic Article
-
Prophylaxis of Venous Thromboembolism in Stroke Patients Academic Article
-
Rationale Behind the Development of Low Molecular Weight Heparin Derivatives Academic Article
-
Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides Academic Article
-
Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s Academic Article
-
The Additive Effect of Low Molecular Weight Heparins on Thrombin Inhibition by Dermatan Sulfate Academic Article
-
The haemorrhagic and antithrombotic effects of dermatan sulphate. Academic Article
-
The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate Academic Article
-
The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin Academic Article
-
Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa Academic Article
-
Vasoflux, a New Anticoagulant With a Novel Mechanism of Action Academic Article
-
Venous thromboembolism in heparin-induced thrombocytopenia Academic Article